🔎 Trials Near Me

Početna › Tumori mozga › Ohio › Columbus

Kliničke studije za Tumori mozga u gradu Columbus, OH

11 studija za Tumori mozga traži sudionike na lokacijama u gradu Columbus i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

U tijeku regrutacijaFaza 2
  • Ohio State University, Columbus
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07326566

SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases

U tijeku regrutacijaFaza 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT04923542

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

U tijeku regrutacijaFaza 2
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • i još 15
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT04511013

Targeted Pediatric High-Grade Glioma Therapy

U tijeku regrutacijaOpažajna studija
  • Nationwide Children's Hospital, Columbus
12 Months – 39 Years · Oba spola · Ažurirano 8. ruj 2026. · NCT05839379

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

U tijeku regrutacijaFaza 2
  • The Ohio State University College of Medicine (OSUCOM), Columbus
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT07428616

Study of Olutasidenib and Temozolomide in HGG

U tijeku regrutacijaFaza 2
  • Nationwide Children's Hospital, Columbus
Od 12 do 39 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT06161974

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

U tijeku regrutacijaFaza 2
  • Nationwide Children's Hospital, Columbus
Od 1 do 26 godina · Oba spola · Ažurirano 4. kol 2026. · NCT07680439

Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain

U tijeku regrutacijaFaza 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 11. lip 2026. · NCT05588453

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

U tijeku regrutacijaFaza 2
  • Nationwide Children's Hospital, Columbus
12 Months – 39 Years · Oba spola · Ažurirano 29. svi 2026. · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

U tijeku regrutacijaFaza 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 13. tra 2026. · NCT06810544

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

U tijeku regrutacijaFaza 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 8. tra 2026. · NCT05987644

Studije za Tumori mozga u drugim gradovima

Ostale studije u gradu Columbus

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.